Betahydroxyfentanyl

Fentanyl numbering

Betahydroxyfentanyl is a potent opioid analgesic that is an analog of fentanyl. Like fentanyl, betahydroxyfentanyl is used for managing acute or chronic pain, but it has not been as widely studied or used in medical practice. Due to its high potency, it has potential for abuse and has been encountered in the illicit drug market. This substance acts on the mu-opioid receptor in the brain to produce effects such as analgesia (pain relief), euphoria, respiratory depression, and sedation.

Chemistry

Betahydroxyfentanyl is chemically related to fentanyl, which is a synthetic opioid analgesic. The addition of a hydroxy group at the beta position of the fentanyl molecule distinguishes it from its parent compound, potentially altering its pharmacological properties. The precise chemical name for betahydroxyfentanyl is N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]-beta-hydroxybutanamide.

Pharmacology

The pharmacological profile of betahydroxyfentanyl is similar to that of other opioids. It exerts its effects primarily by binding to and activating the mu-opioid receptor in the central nervous system. This action inhibits the transmission of pain signals in the brain, leading to pain relief. However, like other opioids, it can also cause side effects such as nausea, vomiting, constipation, and severe respiratory depression, which can be fatal.

Legal Status

The legal status of betahydroxyfentanyl varies by country, but it has been listed as a controlled substance in several jurisdictions due to its potential for abuse and harm. In countries where it is controlled, manufacturing, possession, and distribution of betahydroxyfentanyl without a license are illegal.

Abuse and Illicit Use

Betahydroxyfentanyl has been encountered in the illicit drug market, where it is often mixed with other substances or misrepresented as other opioids, which can increase the risk of overdose and death. Its high potency means that even small amounts can be extremely dangerous, especially to individuals who are not tolerant to opioids.

Health Risks

The health risks associated with betahydroxyfentanyl are similar to those of other potent opioids. These include the risk of addiction, overdose, and death. Overdose can lead to severe respiratory depression, coma, and death. The risk of overdose is heightened when betahydroxyfentanyl is combined with other depressant substances, such as alcohol or benzodiazepines.

Treatment of Overdose

Treatment of a betahydroxyfentanyl overdose is similar to that of other opioid overdoses. It involves the administration of naloxone, an opioid antagonist that can rapidly reverse the effects of opioids. However, due to the high potency of betahydroxyfentanyl, multiple doses of naloxone may be required to effectively reverse an overdose.

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian